Vairavan Latha (CIK 2065881) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-13). Recent activity: Sell ARQT (435 shares), Buy ARQT (27,000 shares), Sell ARQT (2,772 shares), Sell ARQT (81 shares), Sell ARQT (1,320 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Sell | 435 | $9,157 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Buy | 27,000 | $0 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Sell | 2,772 | $69,744 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Sell | 81 | $2,099 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Sell | 1,320 | $33,660 |
| 2025-11-05 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Sell | 88 | $2,175 |
| 2025-08-05 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Sell | 89 | $1,275 |
| 2025-05-07 | Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | Buy | 20,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-13